Denali Therapeutics (DNLI) FCF Margin (QoQ) (2018 - 2023)
Denali Therapeutics (DNLI) FCF Margin (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -617,431.00 |
| Jun 30, 2023 | 14,527.00 |
| Mar 31, 2023 | 53,917.00 |
| Dec 31, 2022 | 76,942.00 |
| Sep 30, 2022 | -139,848.00 |
| Jun 30, 2022 | 7,665.00 |
| Mar 31, 2022 | -1,936.00 |
| Dec 31, 2021 | 62,818.00 |
| Sep 30, 2021 | -43,587.00 |
| Jun 30, 2021 | 32,519.00 |
| Mar 31, 2021 | -83,173.00 |
| Dec 31, 2020 | 14,891.00 |
| Sep 30, 2020 | 76,483.00 |
| Jun 30, 2020 | 10.57 Mn |
| Sep 30, 2019 | 18,649.00 |
| Jun 30, 2019 | -30,960.00 |
| Mar 31, 2019 | -83,143.00 |
| Dec 31, 2018 | 315,066.00 |
| Sep 30, 2018 | -55,472.00 |
| Jun 30, 2018 | -772,278.00 |